Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Other Non-Current Assets: 2020-2025

Historic Other Non-Current Assets for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $3.8 million.

  • Caribou Biosciences' Other Non-Current Assets fell 20.27% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year decrease of 20.27%. This contributed to the annual value of $5.5 million for FY2024, which is 248.11% up from last year.
  • Caribou Biosciences' Other Non-Current Assets amounted to $3.8 million in Q3 2025, which was up 4.28% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Other Non-Current Assets registered a high of $5.5 million during Q4 2024, and its lowest value of $810,000 during Q3 2021.
  • Over the past 3 years, Caribou Biosciences' median Other Non-Current Assets value was $1.8 million (recorded in 2024), while the average stood at $2.9 million.
  • Per our database at Business Quant, Caribou Biosciences' Other Non-Current Assets slumped by 61.63% in 2022 and then surged by 248.11% in 2024.
  • Quarterly analysis of 5 years shows Caribou Biosciences' Other Non-Current Assets stood at $975,000 in 2021, then surged by 57.74% to $1.5 million in 2022, then climbed by 3.12% to $1.6 million in 2023, then surged by 248.11% to $5.5 million in 2024, then dropped by 20.27% to $3.8 million in 2025.
  • Its Other Non-Current Assets was $3.8 million in Q3 2025, compared to $3.6 million in Q2 2025 and $5.0 million in Q1 2025.